AGP Limited (PSX:AGP)
220.70
+5.56 (2.58%)
At close: Jan 16, 2026
AGP Limited Market Cap
AGP Limited has a market cap or net worth of 61.8 billion as of January 16, 2026. Its market cap has increased by 29.75% in one year.
Market Cap
61.80B
Enterprise Value
73.57B
Revenue
27.73B
Ranking
n/a
PE Ratio
16.73
Stock Price
220.70
Market Cap Chart
Since March 5, 2018, AGP Limited's market cap has increased from 23.52B to 61.80B, an increase of 162.74%. That is a compound annual growth rate of 13.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 60.24B | 5.90% |
| Dec 31, 2025 | 56.88B | 19.43% |
| Dec 31, 2024 | 47.63B | 141.93% |
| Dec 29, 2023 | 19.69B | 8.19% |
| Dec 30, 2022 | 18.20B | -32.99% |
| Dec 31, 2021 | 27.16B | -14.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 135.90B |
| Abbott Laboratories (Pakistan) | 118.56B |
| The Searle Company | 77.05B |
| Highnoon Laboratories | 55.13B |
| Shifa International Hospitals | 35.70B |
| Citi Pharma | 19.66B |
| Ferozsons Laboratories | 17.84B |
| Macter International | 15.62B |